Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Nucl Med Technol. 2013 Mar;41(1):11-8. doi: 10.2967/jnumed.110.076315. Epub 2013 Feb 8.

Brain amyloid imaging.

Author information

  • 1Department of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Australia. christopher.rowe@austin.org.au

Abstract

Imaging of brain β-amyloid plaques with (18)F-labeled tracers for PET will likely be available in clinical practice to assist the diagnosis of Alzheimer disease (AD). With the rapidly growing prevalence of AD as the population ages, and the increasing emphasis on early diagnosis and treatment, brain amyloid imaging is set to become a widely performed investigation. All physicians reading PET scans will need to know the complex relationship between amyloid and cognitive decline, how to best acquire and display images for detection of amyloid, and how to recognize the patterns of tracer binding in AD and other causes of dementia. This article will provide nuclear medicine physicians with the background knowledge required for understanding this emerging investigation, including its appropriate use, and prepare them for practical training in scan interpretation.

PMID:
23396994
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk